Key facts
- ReadyGo (Diagnostic Equipment)’s last known valuation is $31.6M (Mar 2025).
- It has raised $5.5M; the latest was Later Stage VC ($2.5M) in Mar 2025.
- Notable investors include Maven Capital Partners UK, Midlands Engine Investment Fund, Foresight Group.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ReadyGo (Diagnostic Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for ReadyGo (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReadyGo (Diagnostic Equipment)
Developer of a healthcare diagnostics platform intended for the detection of different diseases. The company's platform has a commercially ready all-in-one sample collection/preparation device designed for isothermal-based testing and detection of multiple infections, including coronavirus and influenza and also for testing for viral conjunctivitis, herpes and dengue fever which can last for up to several different tests simultaneously, enabling users to get detected for all kinds of infections rapidly and accurately.
- Sector
- Healthcare
- HQ
- Bath, United Kingdom
- Founded
- 2016
- Employees
- 10
- Website
- readygotest.com/
- Ownership
- Privately Held (backing)
ReadyGo (Diagnostic Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReadyGo (Diagnostic Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReadyGo (Diagnostic Equipment) in its N-PORT filings yet. We sweep new filings monthly.